US pediatricians criticize RFK Jr's new vaccine panel: ‘Truly an embarrassment'
Robert F Kennedy Jr's newly appointed vaccine advisory panel is facing criticism from pediatricians after its announcement of plans to reassess the current vaccination schedules for children and adolescents.
Experts warn that the move appears designed to undermine public trust in immunization.
The chair of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases, Dr Sean O'Leary, said during a Wednesday press briefing that the rest of the world is looking at the US and its new Advisory Committee on Immunization Practices (ACIP) 'in horror'.
'It is truly an embarrassment at this point, what's happening with ACIP,' said O'Leary.
While the new ACIP has instigated chaos among vaccine policy infrastructure during their Wednesday meeting, the AAP emphasized a need to continue a commitment to publishing independent, science-based vaccine guidelines.
Wednesday marked the first ACIP meeting since health secretary Kennedy dismissed all 17 existing voting members and installed eight new ones, a group that reportedly lost one member before the meeting convened. Some of these new appointees have been associated with the spread of vaccine misinformation.
The AAP representatives abstained from participating because they view the new ACIP as 'illegitimate'. The AAP's own meeting was scheduled to immediately follow the ACIP session, giving pediatric experts an opportunity to respond to the new committee's statements and direction.
'What we heard in this meeting was really a false narrative that the current vaccine policies are flawed and that they need fixing. That's completely false,' said O'Leary.
'Vaccine policies have saved millions of lives, trillions of dollars, and our immunization system is a model for the rest of the world.'
Among ACIP's early initiatives is a separate working group that plans to examine vaccines that have not undergone a recent review, specifically those not studied in over seven years. One vaccine that drew immediate attention is the hepatitis B birth dose. O'Leary criticized the focus on reviewing vaccine schedules, which he says 'has been an anti-vaccine trope for many, many years'.
A schedule review 'sounds good at first glance, but the fact is, these vaccines are essentially always being reviewed in real time through a number of different mechanisms, safety surveillance mechanisms, as well as disease surveillance mechanisms', O'Leary said.
'The hepatitis B birth dose is one of the cornerstones of our hepatitis B prevention policy here in the US, and it has been highly successful in reducing the rate of perinatally acquired hepatitis B,' he added.
An AAP article says that infants infected with hepatitis B at birth face a 90% likelihood of developing chronic infection. Without medical intervention, roughly 25% of those children will die from the disease.
Kennedy's decision to overhaul ACIP has sparked concern among medical professionals. The new panel's review includes vaccines like the MMR shot, which protects against measles, mumps, rubella, and varicella (chickenpox), as well as the hepatitis B vaccine given at birth.
'We do still need to maintain higher coverage in the US of MMR, you're seeing the measles outbreaks in real time,' O'Leary said.
'We need to maintain very high measles vaccination coverage. And this ACIP discussion, to me, is designed to sow distrust in measles vaccination.'
The US is now enduring the largest measles outbreak in decades. Centered in west Texas, the measles outbreak has killed two unvaccinated children and one adult and spread to neighboring states. Measles had been declared eliminated from the US in 2000, but it has been spreading in under-vaccinated communities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
29 minutes ago
- Daily Mail
America becomes cancer capital of the WORLD with more cases than all but one country
America has surpassed all but one country in new cancer diagnoses, making it a cancer capital of the world. The US saw 2.4million new cases of cancer in 2022, surpassing all but China, which saw nearly 4.8million. However, the US saw a higher rate than the Asian country - 1,307 cases per 100,000 people, compared to China's 490 per 100,000. Overall, the US has the fifth-highest cancer rate in the world, and cases are climbing. America made up about 13 percent of the 19 million cases recorded worldwide in 2022, more than the combined share from all of Africa (six percent), Latin America and the Caribbean (seven percent), and Oceania (less than two percent). And global diagnoses are only expected to increase, reaching 35million a year by 2050. Lung cancer was the most commonly diagnosed among both men and women, responsible for almost 2.5 million new cases, or one in eight cancers worldwide. In the US, an estimated 236,740 new cases of lung cancer were diagnosed, and 130,000 people died. Breast cancer in women made up 12 percent of cases worldwide, colorectal accounted for 10 percent, prostate at seven percent, and stomach at five percent. Cancer is now the leading cause of death in Americans under 85, according to the American Cancer Society's 2024 report. While it remains the second-leading cause of death overall in the US, it has surpassed heart disease as the top killer in younger age groups. The anticipated spike in new cancer diagnoses is mainly due to population growth and aging, but experts are increasingly blaming environmental toxins and ultra-processed foods. And though cancer rates among people under 50 are on the rise, particularly colorectal cancer, the disease still primarily afflicts seniors. 'This rise in projected cancer cases by 2050 is solely due to the aging and growth of the population, assuming current incidence rates remain unchanged,' Dr Hyuna Sung, senior principal scientist at the American Cancer Society, said. 'Notably, the prevalence of major risk factors such as consumption of unhealthy diet, physical inactivity, heavy alcohol consumption, and cigarette smoking are increasing in many parts of the world and will likely exacerbate the future burden of cancer barring any large scale interventions.' Experts warn that the projected rise in cancer cases by 2050 stems from more than just aging populations. Population growth explains part of the increase, but preventable risk factors —poor diet, lack of access to screenings, and chemical exposures — are also driving the disproportionate spikes. While the US diagnoses about one in six global cancer cases, it accounts for just seven percent of deaths worldwide, thanks to advanced treatments and fast drug approvals. The American Cancer Society reported that almost half of all cases and about 56 percent of cancer deaths in 2022 occurred in Asia, where over 59 percent of the world's population lives. Cancer death rates in Africa and Asia are much higher than cases, partly because cancers there are often found late and are harder to treat. Europe has more cancer cases and deaths than expected for its population, making up about 20 percent of global cases and deaths, though it has less than 10 percent of the world's people. Prostate cancer in men is the most frequently diagnosed cancer in 118 countries, followed by lung cancer among both sexes in 33 countries, and liver, colorectal, and stomach cancer ranking in first place in 11, nine, and eight countries, respectively. By 2050, lung cancer cases will climb from about 2.5 million in 2022 to roughly four million. Deaths will also climb from approximately 1.8 million to about three million. Global breast cancer cases are projected to surge from 2.3 million to 3.5 million by 2050, with deaths rising from 666,000 to 1 million. Breast cancer is the most common cancer in women (excluding skin cancer), diagnosed in 157 countries, while cervical cancer leads in 25 others. The US saw 288,000 new cases in 2022, with over 319,000 projected for 2025. Just 10 cancer types cause over 60 percent of all cases and deaths globally. Leading the pack is lung cancer (12.4 percent of cases), followed by breast (11.6 percent), colorectal (9.6 percent), prostate (7.3 percent), and stomach cancers (4.9 percent). Colorectal cancer cases will skyrocket from 1.9 million to 3 million globally by 2050, fueled by processed diets and rising early-onset cases. In 2023, 19,550 Americans under 50 were diagnosed with CRC. Deaths will climb from 904,000 to 1.4 million, especially in regions with poor screening. In North America, pancreatic cancer cases and deaths will both increase sharply, with minimal survival improvements expected. Obesity and diabetes are key drivers. Prostate cancer is set to explode—from 1.5 million cases today to a staggering 2.5 million by 2050—as the world's population ages. Deaths will leap from 397,000 to 600,000, hitting sub-Saharan Africa hardest, where life-saving treatments remain out of reach for millions. Liver cancer cases will rise from 865,000 to 1.2 million. Deaths will remain high, nearing one million, due to late detection in poorer parts of the world. It's on track to become more common, fueled by America's growing struggles with obesity, diabetes, and heavy drinking—even as hepatitis-linked cases fade. Deaths will climb in lockstep, as most patients are diagnosed too late for effective treatment. Cervical cancer cases could plummet from 660,000 to 500,000 with wider HPV vaccination, yet deaths may persist in Africa without better screening. Meanwhile, North America could nearly eliminate it, thanks to vaccines and early detection. Stomach cancer cases will decline slightly due to H. pylori control, but deaths will persist in regions with limited healthcare. Pancreatic cancer cases will spike from 511,000 to 800,000, with deaths mirroring this rise due to poor survival rates. Esophageal cancer cases will grow from 511,000 to 700,000, driven by obesity-related adenocarcinoma in wealthy nations. While cases in the US are rising, deaths due to cancer are on the decline thanks to advances in treatments. Scientists can now engineer immune cells in the lab that target and kill cancer cells, while CRISPR-based gene therapies have progressed from the lab to clinical trials for people with cancer. Dr Karen E Knudsen, CEO of the American Cancer Society, said: 'Understanding the global cancer burden is critical to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. 'This data provides insight into trends and potential areas for intervention and can help prioritize discovery efforts worldwide.
Reuters
an hour ago
- Reuters
UnitedHealth appoints new CEO to run health services division
NEW YORK, June 26 (Reuters) - UnitedHealth Group's (UNH.N), opens new tab health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo. A spokesperson for UnitedHealth said Conway's experience in value-based care, where payment is generated from keeping patients healthy, drove the health insurer's new appointment. 'Leadership changes are consistent with the company's longstanding, intentional approach to develop an executive team with a range of experiences across its diverse portfolio of businesses," the spokesperson said. The company named former Optum Health CEO Amar Desai as vice-chairman of the unit. UnitedHealth Group named a new company-wide CEO, veteran Stephen Hemsley, to steer the healthcare giant following its first earnings miss since 2008. Conway in April was appointed CEO of UnitedHealth's Optum segment, which operates its Optum Health unit, and previously ran its Optum Rx pharmacy benefit manager. Optum Health, which operates medical clinics and offers nursing services, serves as UnitedHealth's healthcare delivery arm. In a first-quarter earnings call, UnitedHealth detailed underperforming revenue at Optum Health, citing reduced engagement from Medicare Advantage patients. A May Wall Street Journal report detailed a criminal probe by the Department of Justice on UnitedHealth's billing practices, related to in-home visits it conducts within Optum Health. Hemsley in a June shareholder meeting said that the company was undertaking a review of practices across its business, apologizing for recent underperformance in earnings.
The Independent
an hour ago
- The Independent
Oklahoma seeks to exclude soda, candy from food stamp purchases
Oklahoma Gov. Kevin Stitt said Thursday the state is seeking federal permission to exclude soft drinks and candy from the list of items that can be purchased under the benefit for low-income Americans long known as food stamps. Stitt made the announcement during an event at the Capitol with U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. as part of the 'Make America Healthy Again' initiative. Oklahoma would join several other states that already have sought federal waivers from the U.S. Department of Agriculture to prohibit the purchase of items such as soda and energy drinks under the Supplemental Nutrition Assistance Program, or SNAP. 'If you want to drink a bottled soda, you should be able to have that right,' Kennedy said. 'But the federal government should not be paying for it with taxpayer money.' SNAP is a roughly $100 billion program that serves about 42 million Americans and is run by the U.S. Agriculture Department and administered through states. Stitt also signed an executive order on Thursday calling into question the appropriateness of mandatory fluoridation of public drinking water and the use of commonly used artificial food coloring, including Red Dye 40. Under the order, the Oklahoma State Department of Health and Department of Equality are directed to immediately stop any endorsement of fluoridation of the public water supply. Although Stitt said each local municipality will still have the autonomy to make a decision to continue the practice, which has long been encouraged as a means of promoting dental health. Under the order, the two state agencies are directed to conduct a comprehensive review of water fluoridation and make recommendations for transitioning away from the practice. Stitt also said he would direct agencies that provide meals, including prisons and public schools, to discontinue the use of artificial dyes in food. 'Today we're going to get the ball rolling on making Oklahoma healthy again,' Stitt said.
